Study of the anticancer effect of new quinazolinone hydrazine derivatives as receptor tyrosine kinase inhibitors

The advent of novel receptor tyrosine kinase inhibitors has provided an important therapeutic tool for cancer patients. In this study, a series of quinazolinone hydrazide triazole derivatives were designed and synthesized as novel MET (c-MET) receptor tyrosine kinase inhibitors. The antiproliferativ...

Descripción completa

Detalles Bibliográficos
Autores principales: Mortazavi, Motahareh, Divar, Masoumeh, Damghani, Tahereh, Moosavi, Fatemeh, Saso, Luciano, Pirhadi, Somayeh, Khoshneviszadeh, Mehdi, Edraki, Najmeh, Firuzi, Omidreza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Chemistry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9713320/
https://www.ncbi.nlm.nih.gov/pubmed/36465863
http://dx.doi.org/10.3389/fchem.2022.969559

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9713320/
https://www.ncbi.nlm.nih.gov/pubmed/36465863
http://dx.doi.org/10.3389/fchem.2022.969559

Ejemplares similares